Dannex Ayrton Starwin makes the medicines and basic health products Ghana relies on every day. Its story is one of steady local demand, thin margins, and a disclosure calendar that has slipped behind schedule. Full nameDannex Ayrton Starwin PLC Tickers / exchangeDASPHARMA / Ghana Stock Exchange (GSE) HeadquartersNot published in available primary sources SectorPharmaceuticals EmployeesNot published in available primary sources Market valueNot published in available primary sources Yearly salesGH¢173,108,660 (US$14.7m) — year ended 31 Dec 2024 Net profitGH¢10,407,411 (US$0.89m) — year ended 31 Dec 2024 Net margin6.0% (our calculation) Return …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →